跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,800 条关于
“hepatic fibrosis”
全部
10,800
临床试验
9,073
药物
196
机构
20
资讯
1,511
7年前
FDA Approves Resmetirom (Rezdiffra) for Treating MASH and Associated Fibrosis
去年
Icosabutate Shows Promising Anti-Fibrotic Results in Phase 2b MASH Trial
10个月前
Mabwell's Anti-IL-11 Antibody 9MW3811 Becomes World's First IL-11 Therapeutic to Enter Phase II for Pathological Scarring
去年
TREM2 Emerges as Dual Regulator of Lipid Metabolism and Immune Response in MASH
去年
Juvena Therapeutics Partners with Eli Lilly in AI-Driven Muscle Health Drug Discovery Collaboration
去年
Adverse Events of Hepatic Anti-Fibrotic Agents in Phase 3 and Above Clinical Trials
去年
Vertex's ALYFTREK Approved by FDA as Next-Generation Cystic Fibrosis Treatment
6个月前
NorthSea Therapeutics Secures Orphan Drug Designations for Orziloben in Rare Liver Disease
10个月前
MetaVia's Vanoglipel Shows Dual Benefits in MASH Phase 2a Trial with Significant HbA1c Reduction and Liver Improvements
29天前
FDA Grants Accelerated Approval to Ultragenyx's GENGLYCOS, First Gene Therapy for Glycogen Storage Disease Type Ia
第 1 页,共 152 页
上一页
下一页